Trial intelligence / Profile preview

EVL and Carvedilol for First Variceal Bleeding Prophylaxis

NCT01383044Phase 4Terminated

Sponsor
E-Da Hospital
Start
Jul 2011
Primary completion
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of carvedilol in esophageal varices, sponsored by E-Da Hospital. Started Jul 2011; status: terminated.

02

Drugs

carvedilol
03

Conditions

esophageal varices

Beyond the preview

Go deeper on NCT01383044.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01383044.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call